Tryptophan as the fingerprint for distinguishing aggressiveness among breast cancer cell lines using native fluorescence spectroscopy

Journal of Biomedical Optics

Volumn 19, Issue 3, 2014, Pages

  Zhang, Lin ^a   Pu, Yang ^b   Xue, Jianpeng ^c   Pratavieira, Sebastião ^b,d   Xu, Baogang ^c   Achilefu, Samuel ^c   Alfano, Robert R ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY COLLEGE OF NEW YORK   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

aggressive breast cancer cells; cancer markers; metastasis; native fluorescence spectroscopy; tryptophan

Indexed keywords

AMINO ACIDS; CELL CULTURE; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; PATHOLOGY;

BREAST CANCER CELLS; CANCER CELLS; CANCER MARKERS; CELL LINES; FLUORESCENCE INTENSITIES; METASTASIS; TRYPTOPHAN;

CELLS;

TRYPTOPHAN; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CHEMISTRY; CLASSIFICATION; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; METHODOLOGY; SPECTROFLUOROMETRY; SUPPORT VECTOR MACHINE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; SPECTROMETRY, FLUORESCENCE; SUPPORT VECTOR MACHINES; TRYPTOPHAN; TUMOR MARKERS, BIOLOGICAL;

EID: 84897129362     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.3.037005     Document Type: Article

References (33)

1. S. Gout and J. Huot, "Role of cancer microenvironment in metastasis: focus on colon cancer," Cancer Microenviron. 1(1), 69-83 (2008).
2. J. A. Marcia et al., Global Cancer. Facts & Figures, American Cancer Society, Atlanta, GA (2007).
3. R. R. Alfano et al., "Laser induced fluorescence spectroscopy from native cancerous and normal tissue," IEEE J. Quantum Electron. 20, 1507-1511 (1984).
4. R. R. Alfano et al., "Light sheds light on cancer-distinguishing malignant tumors from benign tissues and tumors," Bull. N Y Acad. Med. 67 (2), 143-150 (1991).
5. C.-H. Liu et al., "Raman, fluorescence, and time-resolved light scattering as optical diagnostic techniques to separate diseased and normal biomedical media," J. Photochem. Photobiol. B: Biol. 16(2), 187-209 (1992).
6. Y. Zhou et al., "Human brain cancer studied by resonance Raman spectroscopy," J. Biomed. Opt. 17(11), 116021 (2012).
7. R. Rajasekaran et al., "Characterization and diagnosis of cancer by native fluorescence spectroscopy of human urine," Photochem. Photobiol. 89(2), 483-491 (2013).
8. M. Al-Salhi et al., "Lung cancer detection by native fluorescence spectra of body fluids-a preliminary study," J. Fluoresc. 21(2), 637-645 (2011).
9. W. S. Glassman et al., "Ultraviolet excited fluorescence spectra from non-malignant and malignant tissues of gynecological tract," Lasers Life Sci. 5(2), 49-58 (1992).
10. L. A. Sordillo et al., "Optical spectral fingerprints of tissues from patients with different breast cancer histologies using a novel fluorescence spectroscopic device," Technol. Cancer Res. Treat. 12(5), 455-461 (2013).
11. W. Glassman,M. Steiberg, and R. R. Alfano, "Time-resolved and steady state fluorescence spectroscopy from normal and malignant human breast cells lines," Lasers Life Sci. 6, 91-98 (1994). (Pubitemid 24155937)
12. Y. Pu et al., "Native fluorescence spectroscopic evaluation of chemotherapeutic effects on malignant cells using nonnegative matrix factorization analysis," Technol. Cancer Res. Treat. 10(2), 113-120 (2011).
13. A. Pradhan et al., "Time-resolved UV photoexcited fluorescence kinetics from malignant and non-malignant breast tissues," Lasers Life Sci. 4(4), 225-234 (1992).
14. N. Ramanujam et al., "Low temperature fluorescence imaging of freezetrapped human cervical tissues," Opt. Express 8(6), 335-343 (2001).
15. Coriell Cell Respositories, Fibroblast-Catalog ID:GM05399, New Jersey (2013).
16. M. Uchino et al., "Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells," BMC Cancer 10, 414 (2010).
17. C. M. Fillmore and C. Kuperwasser, "Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy," Breast Cancer Res. 10 (2), R25 (2008).
18. Y. Pu et al., "Stokes shift spectroscopic analysis of multifluorophores for human cancer detection in breast and prostate tissues," J. Biomed. Opt. 18(1), 017005 (2013).
19. C. Cortes, "Support-vector networks," Mach. Learning 20(3), 273-297 (1995).
20. W. H. Press et al., "Support vector machines," in Numerical Recipes 3rd Edition: The Art of Scientific Computing, pp. 883-898, Cambridge University Press, New York (2007).
21. Y. Pu et al., "Optical quantitative pathology of cervical intraepithelial neoplasia in human tissues using spatial frequency analysis," J. Biophotonics (2014).
22. M. T. Travers et al., "Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells," Biochim. Biophys. Acta 1661(1), 106-112 (2004). (Pubitemid 38201576)
23. R. D. Schreiber, L. J. Old, and M. J. Smyth, "Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion," Science 331(6024), 1565-1570 (2011).
24. D. M. Pardoll, "The blockade of immune checkpoints in cancer immunotherapy," Nat. Rev. Cancer 12(4), 252-264 (2012).
25. D. B. Shennan et al., "Functional and molecular characteristics of system L in human breast cancer cells," Biochim. Biophys. Acta 1611(1-2), 81-90 (2003). (Pubitemid 36351435)
26. G. C. Prendergast, "Cancer: Why tumours eat tryptophan," Nature 478 (7368), 192-194 (2011).
27. F. Fallarino et al., "T cell apoptosis by tryptophan catabolism," Cell Death Differ. 9(10), 1069-1077 (2002).
28. F. H. Igney and P. H. Krammer, "Immune escape of tumors: apoptosis resistance and tumor counterattack," J. Leukoc. Biol. 71(6), 907-920 (2002).
29. R. Kim, M. Emi, and K. Tanabe, "Cancer immunoediting from immune surveillance to immune escape," Immunology 121(1), 1-14 (2007). (Pubitemid 46537674)
30. A. Alimova et al., "Hybrid phosphorescence and fluorescence native spectroscopy for breast cancer detection," J. Biomed. Opt. 12(1), 014004 (2007).
31. H. Betsunoh et al., "Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma," BMC Cancer 13(1), 509 (2013).
32. A. Huang et al., "Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer," Br. J. Cancer 86(11), 1691-1696 (2002). (Pubitemid 34712909)
33. M. Platten,W. Wick, and B. J. Van den Eynde, "Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion," Cancer Res. 72(21), 5435-5440 (2012).